Sign inJoin waitlistJoin the waitlist

Anne Noonan

Section Chief, Gastrointestinal Oncology · Ohio State University Hospital

Credentials: · · · · ·

History

Gastrointestinal Oncology Section · Ohio State University Hospital
Present

National Cancer Institute
2005–2007
Internal Medicine
2002–2005
Doctor of Medicine
1998–2002

Research

Phase I/Ib study of olaparib and carboplatin in BRCA1 or BRCA2 mutation-associated breast or ovarian cancer with biomarker analyses
Journal of the National Cancer Institute · 2014 · 150 citations
Randomized Phase 2 Trial of the Oncolytic Virus Pelareorep (Reolysin) in Upfront Treatment of Metastatic Pancreatic Adenocarcinoma
Molecular Therapy · 2016 · First of 20 authors · 132 citations
Randomized Phase II Study of PET Response-Adapted Combined Modality Therapy for Esophageal Cancer: Mature Results of the CALGB 80803 (Alliance) Trial
Journal of Clinical Oncology · 2021 · 125 citations

Maryam Lustberg
25 papers
Robert Wesolowski
24 papers
Nicole Williams
22 papers
BR
Bhuvaneswari Ramaswamy
20 papers
Raquel Reinbolt
20 papers
Sagar Sardesai
20 papers
Daniel Stover
18 papers
JV
Jeffrey VanDeusen
18 papers
Matthew Cherian
14 papers
CH
Claire Han
11 papers
Mary Dillhoff
11 papers
Timothy Pawlik
11 papers

Clinical trials

Dasatinib for the Prevention of Oxaliplatin-Induced Neuropathy in Patients With Metastatic Gastrointestinal Cancer Receiving FOLFOX Chemotherapy With or Without Bevacizumab
Principal investigator · Completed · Phase 1
Anne Noonan
2020–2023
Carboplatin and Paclitaxel With or Without Viral Therapy in Treating Patients With Recurrent or Metastatic Pancreatic Cancer
Principal investigator · Completed · Phase 2
National Cancer Institute (NCI)
2010–2016